The PPARα–leukotriene B4 pathway to inflammation control
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Inflammation is a local immune response to 'foreign' molecules, infection and injury. Leukotriene B4, a potent chemotactic agent that initiates, coordinates, sustains and amplifies the inflammatory response, is shown to be an activating ligand for the transcription factor PPARalpha. Because PPARalpha regulates the oxidative degradation of fatty acids and their derivatives, like this lipid mediator, a feedback mechanism is proposed that controls the duration of an inflammatory response and the clearance of leukotriene B4 in the liver. Thus PPARalpha offers a new route to the development of anti- or pro-inflammatory reagents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FFAs act as PPAR agonists facilitating translocation to the nucleus and dimerization to RXR [77,78].”
From Lipoprotein Lipase Regulates Microglial Lipid Droplet Accumulation (2021) · cites this paper as [77]
In the citing paper
“PPAR-α is involved in the regulation of pro-inflammatory genes, mainly by limiting cytokine expression.[109]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [109]
Citations
Cites
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
Samuelsson, B., Dahlén, S.-E., Lindgren, J. Å., Rouzer, C. A., & Serhan, C. N. (1987) · Science · doi:10.1126/science.2820055 · Cited by 2,233
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Self-citationKliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
Kliewer, S. A., Umesono, K., Noonan, D. J., Heyman, R. A., & Evans, R. M. (1992) · Nature · doi:10.1038/358771a0 · Cited by 1,741
Lee, S. S.-T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655
Self-citationKliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400
Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors
Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G., & Wahli, W. (1992) · Cell · doi:10.1016/0092-8674(92)90031-7 · Cited by 1,376
Self-citation
Research works printed but not linked: 6
- Ford-Hutchinson, A. W. Crit. Rev. Immunol. 10, 1–11 (1990).
- Desvergne, B. & Wahli, W. in Inducible Transcription Vol. 1 (ed. Bæuerle, P.) 142–176 (Birkhäuser, Boston, 1995).
- Greene, M. E. et al. Gene Expr. 4, 281–299 (1995).
- Schmidt, A. et al. Mol. Endocrinol. 6, 1634–1641 (1992).
- Yu, K. et al. J. Biol. Chem. 270, 23975–23983 (1995). · DOI · Paper page
- Peters, J. M. et al. Mol. Pharmacol. 50, 67–94 (1996).
Cited by
Items 901–1,000 of 1,001
Steroid Hormones and Other Lipid Molecules Involved in Human Reproduction
Strauss, J. F., & FitzGerald, G. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00004-4 · Cited by 30
Fiedler, J., Simon, F. R., Iwahashi, M., & Murphy, R. C. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29278-8 · Cited by 20
Down‐regulation of uncoupling protein‐3 and ‐2 by thiazolidinediones in C2C12 myotubes
Cabrero, À., Alegret, M., Sánchez, R. M., Adzet, T., Laguna, J. C., & Vázquez‐Carrera, M. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02125-6 · Cited by 20
Myers, K. A., Lambe, K. G., Aldridge, T. C., Macdonald, N., & Tugwood, J. D. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7507 · Cited by 20
Long chain fatty acids as modulators of gene transcription in preadipose cells
Grimaldi, P. A., Teboul, L., Gaillard, D., Armengod, A. V., & Amri, E. (1999) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006899027441 · Cited by 20
“bolite, are specific ligands for the γ isoform [25, 26], whereas PPARα specifically binds leukotriene B4 and fibrates [ 27 ].”
BackgroundCunha, R. Z., Zannoni, A., Salamanca, G., Silva, M. D., Rinnovati, R., Gramenzi, A., Forni, M., & Chiocchetti, R. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1045030 · Cited by 22
“Ligands of PPAR-α have been shown to regulate inflammatory responses (104) so much so that, in PPAR-α deficient mice, abnormally prolonged responses to different inflammatory stimuli have been noted (105).”
BackgroundTherapeutic Potential of Palmitoylethanolamide in Gastrointestinal Disorders
Branković, M., Gmizić, T., Dukić, M., Zdravkovic, M. D., Daskalovic, B., Mrda, D., Nikolić, N., Brajković, M., Gojgić, M., Lalatović, J., et al. (2024) · Antioxidants · doi:10.3390/antiox13050600 · Cited by 20
“As a result, it is well established that animals lacking PPARs have a prolonged duration of inflammation [50].”
Nutrigenomic Functions of PPARs in Obesogenic Environments
Chung, S., Kim, Y. J., Yang, S. J., Lee, Y., & Lee, M. (2016) · PPAR Research · doi:10.1155/2016/4794576 · Cited by 21
“Moreover, various eicosanoids can activate PPARα with a stronger affinity than their PUFA precursors [103, 115, 116].”
BackgroundBeneficial Effect of Bezafibrate on Primary Sclerosing Cholangitis (Three Case Reports)
Kita, R., Kita‐Sasai, Y., Hanaoka, I., Kimura, T., Kokuryu, H., Takamatsu, S., Osaki, Y., Tomono, N., Hachiya, T., & Shimizu, T. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)04225-9 · Cited by 19
Mouthiers, A., Baillet, A., Deloménie, C., Porquet, D., & Mejdoubi‐Charef, N. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0188 · Cited by 22
Lewis, D. F. V., & Lake, B. G. (1998) · Toxicology in Vitro · doi:10.1016/s0887-2333(98)00056-3 · Cited by 19
Leptin rapidly activates PPARs in C2C12 muscle cells
Bendinelli, P., Piccoletti, R., & Maroni, P. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.009 · Cited by 19
Bazinet, R. P., McMillan, E. G., Seebaransingh, R., Hayes, A. M., & Cunnane, S. C. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200153-jlr200 · Cited by 19
Molecular mechanisms of leukotriene synthesis: the changing paradigm
Peters-Golden (1998) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1998.00333.x · Cited by 23
Carboxy-Substituted Cinnamides: A Novel Series of Potent, Orally Active LTB4 Receptor Antagonists
Greenspan, P. D., Fujimoto, R. A., Marshall, P. J., Raychaudhuri, A., Lipson, K. E., Zhou, H., Doti, R. A., Coppa, D. E., Zhu, L., Pelletier, R., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980540v · Cited by 19
Won, T. W. (2013) · Korean Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.14701/kjhbps.2013.17.3.89 · Cited by 20
Population-Specific Genetic and Expression Differentiation in Europeans
Jiang, X., & Assis, R. (2020) · Genome Biology and Evolution · doi:10.1093/gbe/evaa021 · Cited by 18
Bellanti, F., Bukke, V. N., Moola, A., Villani, R., Scuderi, C., Steardo, L., Palombelli, G., Canese, R., Beggiato, S., Altamura, M., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.890855 · Cited by 19
Hu, S., Ai, Y., Hu, C., Bawa, F. N. C., & Xu, Y. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101372 · Cited by 23
Toxic effects of mercuric sulfide on immune organs in mice
Son, H., Lee, S., Park, S.-B., Kim, M.-S., Choi, E., Singh, T. S. K., Bae, Y., Kwack, S. J., Kang, T. S., Shin, H., et al. (2009) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923970903305499 · Cited by 18
The peroxisome proliferator-activated receptor α activator, Wy14,643, is anti-inflammatory in vivo
Colville‐Nash, P., Willis, D., Papworth, J., Freemantle, C. N., Lam, C. N. Y., Andrews, G., & Willoughby, D. A. (2005) · Inflammopharmacology · doi:10.1163/156856005774382724 · Cited by 18
“This supports the hypothesis of Devchand et al. (1996) that PPARα activators should be anti-inflammatory based on their results showing exacerbation of inflammation in PPARα knockout mice in the same model as used here and supporting the work of Sheu et al. (2002) using PPARα agonists to ameliorate…”
BackgroundMethodInfluentialPeroxisome Proliferator-Activated Receptors (PPARs) in Glucose Control
Chiazza, F., & Collino, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801585-8.00009-9 · Cited by 22
Signal Transduction and Molecular Regulation in Fatty Liver Disease
Dong, X. C., Chowdhury, K., Huang, M., & Kim, H.-G. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0076 · Cited by 23
The pleiotropic peroxisome proliferator activated receptors: Regulation and therapeutics
Dixit, G., & Prabhu, A. (2021) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2021.104723 · Cited by 20
Analgesic, Anti-inflammatory, and Anti-pyretic Activity
Vogel, H. G. (2007) · Springer eBooks · doi:10.1007/978-3-540-70995-4_9 · Cited by 20
Melnik, B. C. (2010) · Der Hautarzt · doi:10.1007/s00105-009-1831-0 · Cited by 22
Yamamoto, T., Yokomizo, T., Nakao, A., Izumi, T., & Shimizu, T. (2001) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2001.02462.x · Cited by 18
Shirinsky, I. V., & Shirinsky, V. S. (2011) · International Journal of Rheumatology · doi:10.1155/2011/937843 · Cited by 21
“PPARα activation leads to transcription of genes of the β- and ωoxidation pathways that neutralize and degrade LTB4 itself, thus regulating inflammation by a negative feedback loop [30].”
BackgroundAntioxidant Stress and Anti-Inflammation of PPARαon Warm Hepatic Ischemia-Reperfusion Injury
Gao, Z., & Li, Y. (2012) · PPAR Research · doi:10.1155/2012/738785 · Cited by 20
M�ssner, R., Kaiser, R., Matern, P., Kr�ger, U., Westphal, G., ller, J. R. B., Ziegler, A., Neumann, C. R., K�nig, I., & Reich, K. (2004) · Archives of Dermatological Research · doi:10.1007/s00403-004-0463-6 · Cited by 18
“genes including that for involucrin [7, 8]. An antiinflammatory role of PPARα in the skin is supported by several observations including (1) the downregulation of proinflammatory cytokine production in HaCaT cells after activation of PPARα [9], (2) a prolonged cutaneous response of PPARα-deficient mice to proinflammat…”
Anti‐inflammatory Effect of PPARγ in Cultured Human Mesangial Cells
Xiong, Z., Huang, H.-C., Li, J., Guan, Y., & Wang, H. (2004) · Renal Failure · doi:10.1081/jdi-200031747 · Cited by 18
Role of peroxisome proliferator-activated receptor α in atherosclerosis
Cao, H., Gao, W., & Li, H. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2020 · Cited by 19
Jeon, W.-K., Choi, J., Park, S. J., Jo, E. J., Lee, Y., Lim, S., Kim, J., Letterio, J. J., Liu, F., Kim, S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6146 · Cited by 17
Mousavi, M. S., Shahverdi, A., Drevet, J. R., Akbarinejad, V., Esmaeili, V., Sayahpour, F. A., Topraggaleh, T. R., Rahimizadeh, P., & Masouleh, A. A. M. (2019) · Systems Biology in Reproductive Medicine · doi:10.1080/19396368.2019.1677801 · Cited by 18
“2001), suppression of prolonged inflammatory responses (Devchand et al. 1996), regulation of Table 1.”
BackgroundEvening primrose oil effects on osteoclasts during tooth movement.
Taweechaisupapong, S., Srisuk, N., Nimitpornsuko, C., Vattraphoudes, T., Rattanayatikul, C., & Godfrey, K. (2005) · PubMed · doi:10.1043/0003-3219(2005)75[356:epoeoo]2.0.co;2 · Cited by 17
Mohapatra, S. K., Cole, L. E., Evans, C., Sobral, B., Bassaganya-Riera, J., Hontecillas, R., Vogel, S. N., & Crasta, O. R. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-10 · Cited by 20
“In addition to its role in lipid metabolism, PPARa and g have long been recognized for their influence on inflammatory pathways [ 47 ] mostly by repression of pro-inflammatory gene expression.”
BackgroundLi, J., Li, Z., Gu, L.-J., Choi, K.-J., Kim, D.-S., Kim, H.-K., & Sung, C. K. (2017) · Journal of Natural Medicines · doi:10.1007/s11418-017-1116-3 · Cited by 17
“Leukotriene B4 is a potent chemotactic agent that initiates and amplifies the inflammatory response [25].”
BackgroundMollashahi, M., Abbasnejad, M., & Esmaeili‐Mahani, S. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.05.013 · Cited by 18
Ibarra-Lara, L., Sánchez-Aguilar, M., Soria‐Castro, E., Vargas‐Barrón, J., Roldán, F., Pavón, N., Torres-Narváez, J. C., Cervantes-Pérez, L. G., Pastelín-Hernández, G. S., & Sánchez-Mendoza, A. (2019) · Molecules · doi:10.3390/molecules24020270 · Cited by 17
Stelwagen, K., & Ormrod, D. J. (1998) · Inflammation Research · doi:10.1007/s000110050348 · Cited by 17
Nishioka, T., Hyogo, H., Numata, Y., Yamaguchi, A., Kobuke, T., Komichi, D., Nonaka, M., Inoue, M., Nabeshima, Y., Ogi, M., et al. (2005) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.12.211 · Cited by 17
Leukotrien A4 hydrolase and the committed step in leukotriene B4 biosynthesis
Haeggström, J. Z. (1999) · Clinical Reviews in Allergy & Immunology · doi:10.1007/bf02737600 · Cited by 19
Herbertsson, H., Kühme, T., & Hammarström, S. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1233 · Cited by 17
Bezafibrate for primary biliary cirrhosis
Rudić, J. S., Poropat, G., Krstic, M. N., Bjelaković, G., & Gluud, C. N. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009145 · Cited by 17
Feng, S., Xu, G., Fu, Y., Ding, Q., & Shi, Y. (2023) · ACS Omega · doi:10.1021/acsomega.2c07366 · Cited by 16
Role of PPARs inTrypanosoma cruziInfection: Implications for Chagas Disease Therapy
Hovsepian, E., Penas, F., Mirkin, G. A., & Goren, N. (2012) · PPAR Research · doi:10.1155/2012/528435 · Cited by 18
“The first evidence indicating a potential role for PPARs in the inflammatory response was the demonstration that leukotriene B4, a proinflammatory eicosanoid, binds to PPAR-α and induces the transcription of genes involved in ω- and β-oxidation [21].”
BackgroundFluid Shear Stress Reduces 11β-Hydroxysteroid Dehydrogenase Type 2
Lanz, C.-B., Causevic, M., Heiniger, C. D., Frey, F. J., Frey, B. M., & Mohaupt, M. G. (2001) · Hypertension · doi:10.1161/01.hyp.37.1.160 · Cited by 16
Proceedings in uncovering the mechanism behind peroxisome proliferator-induced hepatocarcinogenesis
Bosgra, S., Mennes, W. C., & Seinen, W. (2004) · Toxicology · doi:10.1016/j.tox.2004.07.015 · Cited by 19
Cytochrome P-450 mRNAs Are Modulated by Dehydroepiandrosterone, Nafenopin, and Triiodothyronine
Singleton, D., Lei, X.-D., Webb, S. J., Prough, R. A., & Geoghegan, T. E. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15276-2 · Cited by 16
“Several hypolipidemic drugs, fatty acids and eicosanoids are reported to bind PPARa, but to date, DHEA or its derivatives have not been shown to be direct acting ligands (Devchand et al., 1996; Forman et al., 1997; Kliewer et al., 1997).”
BackgroundNonalcoholic Fatty Liver Disease
Puri, P., & Sanyal, A. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00053-x · Cited by 17
Grau, R., Díaz‐Muñoz, M. D., Cacheiro‐Llaguno, C., Fresno, M., & Iñiguez, M. A. (2008) · PPAR Research · doi:10.1155/2008/352437 · Cited by 18
Identification of subunits of the 650 kDa 12(S)-HETE binding complex in carcinoma cells
Herbertsson, H., Kühme, T., Evertsson, U., Wigren, J., & Hammarström, S. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33885-2 · Cited by 16
Igarashi, T. M., Yokomizo, T., Tsutsumi, O., Taketani, Y., Shimizu, T., & Izumi, T. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00054.x · Cited by 16
Fernández‐Espejo, E., Ramiro-Fuentes, S., & de Fonseca, F. R. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.08.023 · Cited by 16
“…was oberved to enhance levels of PPAR- in the mouse brain. ince the absence of functional PPAR- in mice leads to ncreased inflammatory responses (Devchand et al., 1996; taels et al., 1998; Cuzzocrea et al., 2006), it indicates that pecific sensitizing factors induced by morphine through PAR-…”
BackgroundFischer, J., Gresnigt, M. S., Werz, O., Hube, B., & Garscha, U. (2021) · The FASEB Journal · doi:10.1096/fj.202100516rr · Cited by 16
Lim, J. J., Suh, Y. P., Faustman, E. M., & Cui, J. Y. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000477 · Cited by 15
Lipid Mediators in Inflammation
Bennett, M., & Gilroy, D. W. (2017) · ASM Press eBooks · doi:10.1128/9781555819194.ch19 · Cited by 21
Pace, E., Ferraro, M., Mody, C. H., Melis, M. R., Scafidi, V., Bonanno, A., Profita, M., Giarratano, A., & Gjomarkaj, M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7292 · Cited by 15
He, K., Wang, Q., Yang, Y., Wang, M., & Pan, Y. (2011) · PPAR Research · doi:10.1155/2011/629728 · Cited by 16
“WY14643 is one of synthetic ligands, which is primarily an activator of PPARα [4, 5].”
BackgroundPRIC295, a Nuclear Receptor Coactivator, Identified from PPAR-Interacting Cofactor Complex
Pyper, S. R., Viswakarma, N., Jia, Y., Zhu, Y., Fondell, J. D., & Reddy, J. K. (2010) · PPAR Research · doi:10.1155/2010/173907 · Cited by 15
Endothelium-dependent vascular responses induced by leukotriene B4
Bäck, M., Sakata, K., Qiu, H., Haeggström, J. Z., & Dahlén, S. (2007) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2007.01.008 · Cited by 15
Bonomo, L., Silva, M., Oliveira, R. D. P., Silva, M. E., & Pedrosa, M. L. (2012) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21410 · Cited by 15
Fluorescent leukotriene B4: potential applications
Sabirsh, A., Wetterholm, A., Bristulf, J., Leffler, H., Haeggström, J. Z., & Owman, C. (2005) · Journal of Lipid Research · doi:10.1194/jlr.d500005-jlr200 · Cited by 15
Involvement of ZIP/p62 in the regulation of PPARα transcriptional activity by p38-MAPK
Diradourian, C., May, C. L., Caüzac, M., Girard, J. R., Burnol, A., & Pégorier, J. P. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.02.002 · Cited by 19
“Natural PPARα ligands are long-chain polyunsaturated fatty acids (especially 20:5n-3 and 22:6n-3 [2]) and their lipooxygenase derived metabolite, leukotriene B4 (LTB4 [3]) whereas hypolipidemic drugs from the fibrate family are specific synthetic ligands (reviewed in [4]).”
BackgroundDownregulation of peroxisome proliferator-activated receptors (PPARs) in nasal polyposis
Cardell, L., Hägge, M., Uddman, R., & Adner, M. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-132 · Cited by 15
“eocosanoid products of the lipooxygenase pathway such as leukotriene B4 and 8-S-hydroxytetraenoic acid (8-S-HETE) activates PPARα [ 15 ], prostaglandin (PG) I2 activates PPARβδ and, 15-HETE and the PGD2 derivative, 15deoxy-∆12,14-PGJ 2 , activates PPARγ [16,17].”
BackgroundTan, J., Shi, M., Li, B., Liu, Y., Luo, S., & Cheng, X. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01962-5 · Cited by 18
“Clorf-ibrate, formerly employed for high cholesterol and tri-glyceride management, falls within the category of fibric acid derivatives [57, 58].”
BackgroundStaphylococcus aureus oleate hydratase produces ligands that activate host PPARα
Radka, C. D., Frank, M. W., Simmons, T. S., Johnson, C. N., Rosch, J. W., & Rock, C. O. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1352810 · Cited by 16
Elfaki, D., Bjornsson, E. S., & Lindor, K. D. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04104.x · Cited by 15
Hypoxia aggravates the burden of yellowstripe goby (Mugilogobius chulae) under atorvastatin exposure
Wang, Y., Tang, T., Ren, J., Zhao, Y., Hou, Y., & Nie, X. (2022) · Aquatic Toxicology · doi:10.1016/j.aquatox.2022.106381 · Cited by 14
Fatty acid‐activated nuclear transcription factors and their roles in human placenta
Duttaroy, A. K. (2006) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.200500272 · Cited by 14
Metabolic Functions of Peroxisome Proliferator-Activated Receptor β / δ in Skeletal Muscle
Gaudel, C., & Grimaldi, P. A. (2007) · PPAR Research · doi:10.1155/2007/86394 · Cited by 14
“…of lipid homeostasis regulation has been considerably improved and numerous studies have particularly demonstrated the roles of the peroxisome proliferator-activated receptors (PPARs) in the control of lipid metabolism, providing new ideas about the pharmacological treatment of metabolic syndrome.”
BackgroundRaposo, H. F. (2010) · Revista de Nutrição · doi:10.1590/s1415-52732010000500017 · Cited by 27
Shiue, Y., Chen, L.-R., Tsai, C.-J., Yeh, C.-Y., & Huang, C.-T. (2013) · Biomarkers and Genomic Medicine · doi:10.1016/j.gmbhs.2013.04.008 · Cited by 15
Altomare, A., Corrado, A., Maruotti, N., Cici, D., & Cantatore, F. P. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06457-z · Cited by 14
Drug targets in inflammation and immunomodulation
Buckle, D. R., & Hedgecock, C. J. R. (1997) · Drug Discovery Today · doi:10.1016/s1359-6446(97)01074-x · Cited by 14
Yang, Q., & Gonzalez, F. J. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.08.016 · Cited by 14
Self-citationCholesterol-receptor-mediated genomics in health and disease
Kaul, D. (2003) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.08.010 · Cited by 15
Jouzeau, J., Moulin, D., Koufany, M., Sébillaud, S., Bianchi, A., & Netter, P. (2008) · Journal de la Société de Biologie · doi:10.1051/jbio:2008034 · Cited by 15
Lewis, D. F. V., Jacobs, M. N., Dickins, M., & Lake, B. G. (2002) · Toxicology in Vitro · doi:10.1016/s0278-6915(02)00049-2 · Cited by 14
Fatty Acids in Control of Gene Expression
Gustafsson, J.-Α. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1998.tb01682.x · Cited by 14
Gellrich, L., & Merk, D. (2017) · Nuclear Receptor Research · doi:10.11131/2017/101310 · Cited by 15
“Furthermore PPARα reduces induction of COX-2 [82] and stimulates peroxisomal β-oxidation of leukotriene B4 (LTB4), which is important for the negative feedback control of inflammatory lipid mediators [131].”
BackgroundNicolas-Francès, V., Arnauld, S., Kaminski, J., van Themaat, E. V. L., Clémencet, M.-C., Chamouton, J., Athias, A., Grober, J., Gresti, J., Degrace, P., et al. (2013) · Biochimie · doi:10.1016/j.biochi.2013.11.014 · Cited by 14
“A crucial piece of evidence that liver Thb is functionally regulated by the nuclear receptor PPARa is the observation that some hepatic fatty acid contents are different betweenWTand Thb / mice exposed to the PPARa agonist Wy [21,24].”
BackgroundZagryagskaya, A. N., Aleksandrov, D. A., Pushkareva, M. A., Galkina, S. I., Grishina, Z. V., & Sud’ina, G. F. (2008) · Journal of Immunotoxicology · doi:10.1080/15476910802482888 · Cited by 13
“Thus, an activation of PPARα nuclear receptors has to be considered as a way for termination of inflammatory response.”
BackgroundInfluentialLanggartner, D., Amoroso, M., Kempter, E., Kustermann, M., Scheurer, J., Lowry, C. A., Strauß, G., & Reber, S. O. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.01.018 · Cited by 13
PPARs at the crossroads of T cell differentiation and type 1 diabetes
Riaz, F., Wei, P. Y., & Pan, F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1292238 · Cited by 14
Kim, S., Kiyosawa, N., Burgoon, L. D., Chang, C. C., & Zacharewski, T. R. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.06.004 · Cited by 13
EicosaCell: An Imaging-Based Assay to Identify Spatiotemporal Eicosanoid Synthesis
Bandeira‐Melo, C., Paiva, L. A., Amorim, N., Weller, P. F., & Bozza, P. T. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6759-9_6 · Cited by 13
Astaxanthin alleviates oxidative damage in acute pancreatitis via direct antioxidant mechanisms
Özbeyli, D., Gürler, E. B., Buzcu, H., Çilingir‐Kaya, Ö. T., Çam, M. E., & Yüksel, M. (2020) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2020.19520 · Cited by 13
Thiazolidine Derivatives Attenuate Carrageenan-Induced Inflammatory Pain in Mice
Malik, Z., Abbas, M., Kury, L. T. A., Shah, F. A., Alam, M., Khan, A., Nadeem, H., Alghamdi, S. A., Sahibzada, M. U. K., & Li, S. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s281559 · Cited by 14
“ligands exert additional CNS actions on nociceptive signaling pathways, likely by their action at PPAR receptors in the brain.(47) The involvement of PPARγ in inflammatory processes was first suggested by the antagonism between the activities of proinflammatory cytokines and PPARγ.”
BackgroundEffects of Wuwei Dilong Decoction on Inflammatory Cells and Cytokines in Asthma Model Guinea Pigs
Li, X., Xian-yu, T. U., ZHANG, D.-X., Xu, J., Wang, W., Zhang, Y., & Ya-ming, D. U. (2009) · 中医杂志:英文版 · doi:10.1016/s0254-6272(09)60070-4 · Cited by 13
Ablin, R. J., & Mason, M. D. (2007) · Cancer metastasis · doi:10.1007/978-1-4020-5847-9 · Cited by 16
Importance of blood cellular genomic profile in coronary heart disease
Baba, M. I., Kaul, D., & Grover, A. (2005) · Journal of Biomedical Science · doi:10.1007/s11373-005-9041-y · Cited by 14
Poudrel, J.-M., Hullot, P., Vidal, J., Girard, J., Rossi, J., Müller, A., Bonne, C., Безуглов, В. В., Serkov, I. V., Renard, P., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9910573 · Cited by 13
Han, C. L., Demetris, A. J., Liu, Y., Shelhamer, J. H., & Wu, T. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.a115.404852 · Cited by 13
Todd, J. A. (1996) · Nature · doi:10.1038/384407a0 · Cited by 13
Mulvey, C. K., Ferguson, J. F., Tabita‐Martinez, J., Kong, S. M. Y., Shah, R. Y., Patel, P. N., Master, S. R., Usman, M. H. U., PROPERT, K. J., Shah, R. D., et al. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.002923 · Cited by 15
Tholander, F., Roques, B. P., Fournié‐Zaluski, M., Thunnissen, M. M. G. M., & Haeggström, J. Z. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.06.044 · Cited by 12
PPARα: its role in the human metabolic syndrome
Azhar, S., & Kelley, G. (2007) · Future Lipidology · doi:10.2217/17460875.2.1.31 · Cited by 14
Roles of N-Acylethanolamines in Brain Functions and Neuropsychiatric Diseases
Pistis, M., & Muntoni, A. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_11 · Cited by 13
Yang, R., Xia, F., Su, H., & Wan, J. (2021) · Journal of Chromatography B · doi:10.1016/j.jchromb.2021.122666 · Cited by 12
Metadata
- Authors
- Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., & Wahli, W.
- Affiliations
- University of Lausanne (CH)
- National Institutes of Health (US)
- Venue
- Nature
- Published
- 1996-11
- Volume
- 384
- Issue
- 6604
- Pages
- 39-43
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1671834350
- Cited by
- 1,345
- References
- 43
- Citations by year
- 2026: 3 · 2025: 17 · 2024: 14 · 2023: 21 · 2022: 9 · 2021: 38 · 2020: 30 · 2019: 23 · 2018: 21 · 2017: 24 · 2016: 23 · 2015: 22 · 2014: 43 · 2013: 34 · 2012: 49
- FWCI
- 28.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- PPARα, leukotriene B4, inflammation, transcription factor activation, fatty acid oxidation, lipid mediators, chemotaxis, anti-inflammatory agents, liver, feedback regulation
- MeSH terms
- Adaptation, Physiological, Animals, Cells, Cultured, Fatty Acids, Female, Gene Expression Regulation, HeLa Cells, Humans, Inflammation, Leukotriene B4, Ligands, Liver, Male, Oxidation-Reduction, Plasmids, Pyrimidines, Time Factors, Transcription Factors, Transfection, Chloramphenicol O-Acetyltransferase, Arachidonic Acid, Rats, Sprague-Dawley, Receptors, Cytoplasmic and Nuclear, Inflammation Mediators, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.